Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists.
The safety of calcium channel antagonists has become a controversial issue among cardiologists. Thus, the role of calcium antagonists in the treatment of myocardial infarction is reviewed, and the differences among the 3 classes of calcium channel antagonists, phenylalkylamines, dihydropyridines, and benzothiazepines, are discussed.
Ferrari
R
R
Department of Cardiology, University of Brescia, Gussago, Italy.
D000789:Angina, Unstable / Q000188:drug therapy* / Q000401:mortality; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis
D002121:Calcium Channel Blockers